Skip to main content

Table 3 Grade 3/4 (CTCAE v3.0) bladder and bowel late complications after PET-guided extended-field dose-escalating chemo-IMRT/3D-brachytherapy

From: Patterns of failure after use of 18F-FDG PET/CT in integration of extended-field chemo-IMRT and 3D-brachytherapy plannings for advanced cervical cancers with extensive lymph node metastases

Patient number (%) Supraclavicular, 15 Paraaortic, 31 Pelvic, 26 Total, 72
Bladder 3 (4.2)
 Cystitis 0 1 1 2
 Vesicovaginal fistula 0 1 0 1
Bowel 7 (9.7)
 Rectal ulcer 1 0 0 1
 Proctitis 1 0 0 1
 Rectovaginal fistula 1 1 1 3
 Bowel obstruction 0 1 1 2
  1. Abbreviations: CTCAE v3.0 common terminology criteria for adverse events, version toxicity, IMRT/IGRT intensity-modulated and image-guided radiotherapy, PET fluorodeoxyglucose position emission computed tomography